Key facts
- This page summarizes Martha H. Marsh's Form 4 filing for AMN HEALTHCARE SERVICES INC (AMN).
- 6 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 23 Apr 2024, 15:22.
Martha H. Marsh - 19 Apr 2024 Form 4 Insider Report for AMN HEALTHCARE SERVICES INC (AMN)
- Reporting relationship
- Director
- Issuer ticker
- AMN
- Reported as of
- 19 Apr 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Apr 2024, 15:22:11 UTC
- Prior SEC filing
- 19 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Whitney M. Laughlin, as attorney-in-fact on behalf of Martha H. Marsh
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Martha H. Marsh filed Form 4 for AMN HEALTHCARE SERVICES INC (AMN) on 23 Apr 2024.
Change
- Previous filing in this sequence was filed on 19 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,681
- Change %
- +6.6%
- Price
- $0.000000
- Shares after
- 27,179
- Date
- 19 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
AMN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +6,275
- Change %
- +23%
- Price
- $0.000000
- Shares after
- 33,454
- Date
- 19 Apr 2024
- Ownership
- Direct
- Footnotes
- F2
AMN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +22,575
- Change %
- +67%
- Price
- $0.000000
- Shares after
- 56,029
- Date
- 19 Apr 2024
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AMN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,681
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 19 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,681
- Exercise price
- Footnotes
- F4, F5, F6
AMN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -6,275
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 19 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,275
- Exercise price
- Footnotes
- F6, F7, F8
AMN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -22,575
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 19 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,575
- Exercise price
- Footnotes
- F6, F9, F10
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 10 footnotes
Footnote F1
AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").
Footnote F2
The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on September 21, 2010. The reporting person elected to defer receipt of these RSUs until her retirement from the Company's Board of Directors.
Footnote F3
The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 18, 2012. The reporting person elected to defer receipt of these RSUs until her retirement from the Company's Board of Directors.
Footnote F4
The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.
Footnote F5
The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024. Accordingly, the number of RSUs identified in this row vested on April 19, 2024.
Footnote F6
RSUs do not have an expiration date.
Footnote F7
The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock
Footnote F8
The Restricted Stock Units were granted on September 21, 2010 and vest in the incremental amount of 33% on the earlier of (i) April 13, 2011 or (ii) the date of the Company's 2011 Annual Meeting of Stockholders; 34% on the earlier of (i) April 13, 2012 or (ii) the date of the Company's 2012 Annual Meeting of Stockholders; and 33% on the earlier of (i) April 13, 2013 or (ii) the date of the Company's 2013 Annual Meeting of Stockholders.
Footnote F9
The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.
Footnote F10
The RSUs were granted on April 18, 2012 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2013 Annual Meeting of Shareholders.